Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist

Immunopharmacology

Volumn 43, Issue 2-3, 1999, Pages 187-194

  Pruneau, Didier ^a   Paquet, Jean Luc ^a   Luccarini, Jean Michel ^a   Defrêne, Evelyne ^a   Fouchet, Chantal ^a   Franck, Rose Marie ^a   Loillier, Bruno ^a   Robert, Claude ^a   Bélichard, Pierre ^a   Duclos, Hervé ^a   Cremers, Béatrice ^a   Dodey, Pierre ^a  

^a Laboratoires Fournier SA   (France)

Author keywords

Bradykinin B2 receptors; Guinea pig receptors; Human receptors; Non peptide antagonists; Pharmacology; Rat receptors

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; KALLIDIN[1-9]; KALLIDIN[9 LEUCINE 10 DEARGININE]; LF 160687; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; CHO CELL; CONCENTRATION RESPONSE; CONFERENCE PAPER; DOSE RESPONSE; DRUG ACTIVITY; DRUG RECEPTOR BINDING; EDEMA; GUINEA PIG; HUMAN; HUMAN TISSUE; ILEUM CONTRACTION; ISOLATED ORGAN; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTION; SUBCUTANEOUS DRUG ADMINISTRATION; UTERUS CONTRACTION;

ANIMALS; BLOOD PRESSURE; BLOOD-BRAIN BARRIER; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INOSITOL PHOSPHATES; MALE; MUSCLE CONTRACTION; QUINOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ;

EID: 0032748935     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00128-9     Document Type: Conference Paper

References (25)

1. Aramori, I., Zenkoh, J., Morikawa, N., O'Donnell, N., Asano, M., Nakamura, K., Iwami, M., Kojo, H., Notsu, Y., 1997. Novel subtype-selective nonpeptide bradykinin receptor antagonists FR167344 and FR173657. Mol. Pharmacol. 51, 171-176.
2. 2 receptor antagonist, FR173657. Br. J. Pharmacol. 120, 617-624.
3. 2 antagonist, FR165649, and agonist, FR190997. Br. J. Pharmacol. 124, 441-446.
4. 1 receptor in 293 cells: pharmacological and functional characterization. Br. J. Pharmacol. 122, 393-399.
5. Bhoola, K.D., Figueroa, C.D., Worthy, K., 1992. Bioregulation of kinins: kallikreins, kininogens and kininases. Pharmacol. Rev. 44, 1-80.
6. Bradford, M.M., 1976. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 721, 248-254.
7. 2 receptors to release conjointly endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells. Br. J. Pharmacol. 96, 920-926.
8. Dray, A., Bevan, S., 1993. Inflammation and hyperalgesia: high-lighting the team effort. TIPS 14, 287-290.
9. Dray, A., Perkins, M.N., 1993. Bradykinin and inflammatory pain. Trends Neurosci. 16, 99-104.
10. 2 receptor. Eur. J. Pharmacol. 346, 291-298.
11. Hall, J.M., 1992. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol. Ther. 56, 131-190.
12. Hösli, E., Hösli, L., 1993. Autoradiographic localisation of binding sites for neuropeptide Y and bradykinin on astrocytes. NeuroReport 4, 159-162.
13. 2 receptor antagonist, FR167344. Eur. J. Pharmacol. 333, 79-86.
14. 2 receptor: inter-species variability and dissociation between binding and functional responses. Br. J. Pharmacol. 126, 1083-1090.
15. 2 receptor in the guinea-pig. Br. J. Pharmacol. 116, 2106-2112.
16. 2 receptor. Br. J. Pharmacol. 125, 365-372.
17. 2 receptor antagonist, reduces cerebral edema in a rat model of closed head trauma. Kinin '98 Nara, The 15th International Conference on Kinins, Nara, Japan, October 19-24, 1998.
18. Pruneau, D., Luccarini, J.-M., Fouchet, C., Defrêne, E., Franck, R.-M., Loillier, B., Duclos, H., Robert, C., Cremers, B., Bélichard, P., Paquet, J.-L., 1999. In vitro and in vivo effects of the new nonpeptide bradykinin B, receptor antagonist, LF 16-0335C, on guinea-pig and rat kinin receptors. Fundam. Clin. Pharmacol. 13, 75-83.
19. Raidoo, D.M., Bhoola, K.D., 1997. Kinin receptors on human neurones. J. Neuroimmunol. 77, 39-44.
20. Rees, S., Coote, J., Stables, J., Goodson, S., Harris, S., Lee, M.G., 1996. Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein. Biotechniques 20, 102-104.
21. Regoli, D., Barabé, J., 1980. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32, 1-46.
22. + channels. Stroke 28, 2290-2295.
23. Unterberg, A., Wahl, M., Baethmann, A., 1984. Effects of bradykinin on permeability and diameter of pial vessels in vivo. J. Cereb. Blood Flow Metab. 4, 574-585.
24. Wahl, M., Schilling, L., Unterberg, A., Baethmann, A., 1993. Mediators of vascular and parenchymal mechanisms in secondary brain damage. Acta Neurochir. 57, 64-72.
25. Walker, K., Perkins, M., Dray, A., 1995. Kinins and kinin receptors in the central nervous system. Neurochem. Int. 26, 1-16.